Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 4.01 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 5.82 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 6.03 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 4.53 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 3.54 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 4.8 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 2.99 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 2.74 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 0.0 | BCD100322A01 | 5.22 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 0.5 | BCD100322A03 | 3.27 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 1.0 | BCD100322A07 | 5.57 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 2.0 | BCD100322A11 | 6.24 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 4.0 | BCD100322A15 | 6.34 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 8.0 | BCD100322A19 | 10.8 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 12.0 | BCD100322A23 | 6.15 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | C | 24.0 | BCD100322A27 | 6.62 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 5.08 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 5.76 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 3.01 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 2.87 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 4.35 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 4.35 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 4.36 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol | 0.5 | BCD100322A04 | 7.53 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol | 1.0 | BCD100322A08 | 5.22 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol | 2.0 | BCD100322A12 | 8.48 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol | 4.0 | BCD100322A16 | 5.2 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol | 8.0 | BCD100322A20 | 4.35 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol | 12.0 | BCD100322A24 | 5.78 | pmol/sample |
| LMST01010087 | 24-dihydro Lanosterol | 25OH-Chol | 24.0 | BCD100322A28 | 3.66 | pmol/sample |